Assignee
PHARMACYCLICS INC
US·67 granted patents·58 pending applications·4,176 citations·filing 1994–2015
Top patents by PatentIndex Score
125 records- 0199US9212185B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Dec 15, 2015·44 cites·4 claims
- 0299US9206189B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2014·Granted Dec 8, 2015·41 cites·10 claims
- 0399US9193735B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2014·Granted Nov 24, 2015·41 cites·13 claims
- 0499US9181263B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2015·Granted Nov 10, 2015·40 cites·1 claims
- 0599US9181257B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Nov 10, 2015·65 cites·14 claims
- 0699US9133202B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Sep 15, 2015·37 cites·10 claims
- 0799US9133198B2Inhibitors of bruton'S tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Sep 15, 2015·36 cites·10 claims
- 0899US9127012B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Sep 8, 2015·37 cites·12 claims
- 0999US8975266B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Mar 10, 2015·42 cites·10 claims
- 1099US8957079B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2012·Granted Feb 17, 2015·78 cites·12 claims
- 1199US8759516B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Jun 24, 2014·44 cites·21 claims
- 1299US8008309B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2009·Granted Aug 30, 2011·155 cites·15 claims
- 1399US7960396B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2010·Granted Jun 14, 2011·142 cites·12 claims
- 1499US7825118B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2007·Granted Nov 2, 2010·146 cites·11 claims
- 1599US7741330B1Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2009·Granted Jun 22, 2010·163 cites·16 claims
- 1699US7732454B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2007·Granted Jun 8, 2010·138 cites·12 claims
- 1799US7718662B1Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2009·Granted May 18, 2010·213 cites·16 claims
- 1899US7514444B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2006·Granted Apr 7, 2009·423 cites·8 claims
- 1999US5599928ATexaphyrin compounds having improved functionalizationPHARMACYCLICS INC·Filed 1995·Granted Feb 4, 1997·894 cites·20 claims
- 2098US9133201B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Sep 15, 2015·35 cites·12 claims
- 2198US9125889B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS INC·Filed 2014·Granted Sep 8, 2015·63 cites·2 claims
- 2298US8999999B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS INC·Filed 2013·Granted Apr 7, 2015·66 cites·18 claims
- 2398US8377946B1Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitorsPHARMACYCLICS INC·Filed 2012·Granted Feb 19, 2013·114 cites·19 claims
- 2497US9107924B2Inhibitors of Bruton'S tyrosine kinase for the treatment of solid tumorsPHARMACYCLICS INC·Filed 2013·Granted Aug 18, 2015·40 cites·3 claims
- 2594US7834054B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2009·Granted Nov 16, 2010·16 cites·6 claims
- 2694US5756726AMethods of producing singlet oxygen using compounds having improved functionalizationPHARMACYCLICS INC·Filed 1995·Granted May 26, 1998·65 cites·14 claims
- 2794US5591422ATexaphyrin complexes having improved functionalizationPHARMACYCLICS INC·Filed 1995·Granted Jan 7, 1997·63 cites·19 claims
- 2893US7517988B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Apr 14, 2009·13 cites·15 claims
- 2993US7482466B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Jan 27, 2009·13 cites·12 claims
- 3093US7420089B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Sep 2, 2008·17 cites·10 claims
- 3193US6270749B1Use of Texaphyrin in ocular diagnosis and therapyPHARMACYCLICS INC·Filed 1999·Granted Aug 7, 2001·119 cites·32 claims
- 3292US7547689B2Methods and compositions for treating atheroma, tumors and other neoplastic tissuesPHARMACYCLICS INC·Filed 2006·Granted Jun 16, 2009·12 cites·5 claims
- 3392US7276612B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2004·Granted Oct 2, 2007·39 cites·18 claims
- 3491US8779171B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2013·Granted Jul 15, 2014·9 cites·15 claims
- 3590US9133134B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS INC·Filed 2013·Granted Sep 15, 2015·6 cites·19 claims
- 3690US8026371B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2010·Granted Sep 27, 2011·9 cites·12 claims
- 3789US7625880B2Inhibitors of tyrosine kinases and uses thereofPHARMACYCLICS INC·Filed 2006·Granted Dec 1, 2009·9 cites·20 claims
- 3889US5776925AMethods for cancer chemosensitizationPHARMACYCLICS INC·Filed 1996·Granted Jul 7, 1998·96 cites·34 claims
- 3989US5594136ATexaphyrin solid supports and devicesPHARMACYCLICS INC·Filed 1995·Granted Jan 14, 1997·84 cites·44 claims
- 4088US8900565B2Indole derivatives as inhibitors of histone deacetylasePHARMACYCLICS INC·Filed 2012·Granted Dec 2, 2014·5 cites·2 claims
- 4188US7479502B22-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitorsPHARMACYCLICS INC·Filed 2003·Granted Jan 20, 2009·15 cites·8 claims
- 4287US7838234B2Methods for determining cancer resistance to histone deacetylase inhibitorsPHARMACYCLICS INC·Filed 2008·Granted Nov 23, 2010·3 cites·17 claims
- 4387US5886173AMetallation of macrocycles with 2,4-dicarbonyl-metal complexesPHARMACYCLICS INC·Filed 1997·Granted Mar 23, 1999·50 cites·20 claims
- 4485US8748468B2Manufacture, compositions and uses of coagulation factor VIIa modulatorPHARMACYCLICS INC·Filed 2012·Granted Jun 10, 2014·2 cites·4 claims
- 4585US7820711B2Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disordersPHARMACYCLICS INC·Filed 2007·Granted Oct 26, 2010·7 cites·27 claims
- 4685US6825186B1Method and compositions for treating atheroma, tumors and other neoplastic tissuePHARMACYCLICS INC·Filed 2000·Granted Nov 30, 2004·15 cites·5 claims
- 4784US7160873B2Texaphyrin coordination compounds and uses thereofPHARMACYCLICS INC·Filed 2005·Granted Jan 9, 2007·11 cites·8 claims
- 4883US9096604B2Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS INC·Filed 2013·Granted Aug 4, 2015·5 cites·24 claims
- 4982US8906954B2Selective inhibitors of histone deacetylasePHARMACYCLICS INC·Filed 2013·Granted Dec 9, 2014·4 cites·15 claims
- 5080US7579338B2Methods and compositions for treating atheroma, tumors and other neoplastic tissuesPHARMACYCLICS INC·Filed 2006·Granted Aug 25, 2009·1 cites·6 claims
Showing the top 50 of 125 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PHARMACYCLICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →